{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T11:35:30Z","timestamp":1769600130917,"version":"3.49.0"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,11]]},"abstract":"<jats:sec>\n            <jats:title>Introduction:<\/jats:title>\n            <jats:p>Childhood immune thrombocytopenic purpura (ITP) is a heterogeneous immune-mediated process triggered by infections, vaccines, allergies and parasites. Currently, there is little evidence in the literature beyond case reports of an association with <jats:italic toggle=\"yes\">Toxoplasma gondii<\/jats:italic> (<jats:italic toggle=\"yes\">T. gondii<\/jats:italic>).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>The authors describe the unusual case of an earlier healthy 2.5-year-old Greek boy who developed acute ITP with a life-threatening platelet count a few days after a <jats:italic toggle=\"yes\">T. gondii<\/jats:italic> infection. Evidence for the infection onset was found incidentally 3 months after the initial admission to the hospital and only after any other plausible cause of thrombocytopenia was excluded, according to diagnosis guidelines.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>The boy underwent 3 intravenous immunoglobulin treatments within a trimester, a period during which his alarming platelets count levels led to housebound activities. A quite slow recovery was only ignited after the third treatment, which was administered in conjunction with a mild antibiotic medication for the <jats:italic toggle=\"yes\">T. gondii<\/jats:italic> infection. Full recovery was obtained 9 months after the initial admission, although the boy\u2019s potential scored high in clinical prediction models for developing transient ITP.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>There is a need for more research on ITPs with no obvious cause to investigate a causal association with toxoplasmosis. Currently, testing for diseases of greater rarity and of higher diagnostic cost than <jats:italic toggle=\"yes\">T. gondii<\/jats:italic> is included in the ITP guidelines. Hence, routinely testing for toxoplasmosis when considering potential childhood ITP triggers and infection treatment complementary to treating the ITP might be the key to accelerating the healing process and improving the quality of life of otherwise confined children.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/inf.0000000000004067","type":"journal-article","created":{"date-parts":[[2023,10,20]],"date-time":"2023-10-20T22:04:11Z","timestamp":1697839451000},"page":"e411-e415","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Is Childhood Immune Thrombocytopenia Associated With Acquired Toxoplasmosis? An Unusual Case of Infection That Led to Acute ITP in a Greek Male Toddler and Implications for Guidelines"],"prefix":"10.1097","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-9793-7095","authenticated-orcid":false,"given":"Dimitris","family":"Stogiannis","sequence":"first","affiliation":[{"name":"RDI Statistics Department, National Documentation Centre, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kostas","family":"Blanas","sequence":"additional","affiliation":[{"name":"Maternity Department, Rea Maternity Hospital, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eleni","family":"Tsapra","sequence":"additional","affiliation":[{"name":"Pediatric Department, Euroclinic Children\u2019s Hospital, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marianna","family":"Theodora","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Medical School, National and Kapodistrian University, Greece."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2023,10,11]]},"reference":[{"key":"R1-20250614","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1542\/pir.18.3.75","article-title":"Toxoplasmosis.","volume":"18","author":"Lynfield","year":"1997","journal-title":"Pediatr Rev"},{"key":"R2-20250614","first-page":"135","article-title":"Peripheral thrombopenic purpura associated with acquired toxoplasmosis.","volume":"19","author":"Michez","year":"1998","journal-title":"Rev Med Brux"},{"key":"R3-20250614","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1002\/ajh.25086","article-title":"A comparative prospective observational study of children and adults with immune thrombocytopenia: 2-year follow-up.","volume":"93","author":"Schifferli","year":"2018","journal-title":"Am J Hematol"},{"key":"R4-20250614","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1055\/s-0039-1683416","article-title":"Epidemiology and clinical manifestations of immune thrombocytopenia.","volume":"39","author":"Kohli","year":"2019","journal-title":"Hamostaseologie"},{"key":"R5-20250614","doi-asserted-by":"crossref","first-page":"3780","DOI":"10.1182\/bloodadvances.2019000812","article-title":"Updated international consensus report on the investigation and management of primary immune thrombocytopenia.","volume":"3","author":"Provan","year":"2019","journal-title":"Blood Adv"},{"key":"R6-20250614","doi-asserted-by":"crossref","first-page":"S70","DOI":"10.1053\/j.seminhematol.2016.04.021","article-title":"Viruses, anti-viral therapy, and viral vaccines in children with immune thrombocytopenia.","volume":"53","author":"Elalfy","year":"2016","journal-title":"Semin Hematol"},{"key":"R7-20250614","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1093\/pch\/pxy197","article-title":"Diagnosis and management of typical, newly diagnosed primary immune thrombocytopenia (ITP) of childhood.","volume":"24","author":"Friedman","year":"2019","journal-title":"Paediatric Child Health"},{"key":"R8-20250614","doi-asserted-by":"crossref","first-page":"e2020028","DOI":"10.4084\/mjhid.2020.028","article-title":"Covid-19 and children with immune thrombocytopenia: emerging issues.","volume":"12","author":"Lassandro","year":"2020","journal-title":"Mediterr J Hematol Infect Dis"},{"key":"R9-20250614","first-page":"433","article-title":"Virus-associated immune thrombocytopenic purpura in childhood.","volume":"19","author":"Yenicesu","year":"2009","journal-title":"Hematol Oncol. J"},{"key":"R10-20250614","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.3390\/jcm10071356","article-title":"Epidemiology and viral etiology of pediatric immune thrombocytopenia through korean public health data analysis.","volume":"10","author":"Lim","year":"2021","journal-title":"J Clin Med"},{"key":"R11-20250614","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fped.2021.641535","article-title":"Chronic pediatric immune thrombocytopenia is not associated with herpes virus infection status.","volume":"9","author":"Li","year":"2021","journal-title":"Front Pediatr"},{"key":"R12-20250614","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1007\/s12026-014-8597-x","article-title":"Immune thrombocytopenic purpura (ITP) associated with vaccinations: a review of reported cases.","volume":"60","author":"Perricone","year":"2014","journal-title":"Immunol Res"},{"key":"R13-20250614","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1542\/peds.2011-1111","article-title":"The risk of immune thrombocytopenic purpura after vaccination in children and adolescents.","volume":"129","author":"O\u2019Leary","year":"2012","journal-title":"Pediatrics"},{"key":"R14-20250614","doi-asserted-by":"crossref","first-page":"e427","DOI":"10.1097\/MPH.0000000000000388","article-title":"A case of immune thrombocytopenic purpura after rabies vaccination.","volume":"37","author":"Fulbright","year":"2015","journal-title":"J Pediatr Hematol Oncol"},{"key":"R15-20250614","doi-asserted-by":"crossref","first-page":"e227","DOI":"10.1097\/MPH.0b013e3181e33fe0","article-title":"A case of immune thrombocytopenic purpura after influenza vaccination: consequence or coincidence?","volume":"32","author":"Mantadakis","year":"2010","journal-title":"J Pediatr Hematol Oncol"},{"key":"R16-20250614","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.4161\/hv.23601","article-title":"Vaccine administration and the development of immune thrombocytopenic purpura in children.","volume":"9","author":"Cecinati","journal-title":"Hum Vaccin Immunother"},{"key":"R17-20250614","doi-asserted-by":"crossref","first-page":"71","DOI":"10.14740\/jh789","article-title":"Severe cystic echinococcosis-associated immune thrombocytopenic purpura: a case report.","volume":"10","author":"Bienz","year":"2021","journal-title":"J Hematol"},{"key":"R18-20250614","first-page":"A135","article-title":"Immune thrombocytopenia and instestinal parasitosis - is there a causal link.","volume":"106","author":"\u0160alig","year":"2021","journal-title":"Arch Dis Child"},{"key":"R19-20250614","first-page":"671","article-title":"Acute immune-mediated thrombocytopenic purpura related to Toxoplasma gondii infection.","volume":"12","author":"Tuon","year":"2008","journal-title":"PIDJ"},{"key":"R20-20250614","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1038\/sj.thj.6200558","article-title":"Immune-mediated thrombocytopenic purpura associated with toxoplasma gondii infection in an immunocompetent patient.","volume":"5","author":"Deutsch","year":"2004","journal-title":"Hematol J"},{"key":"R21-20250614","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1002\/ajh.10382","article-title":"Immune thrombocytopenic purpura associated with brucella and toxoplasma infections.","volume":"74","author":"G\u00fcrkan","year":"2003","journal-title":"Am J Hematol"},{"key":"R22-20250614","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1136\/bmj.280.6230.1505-a","article-title":"Chronic thrombocytopenic purpura associated with toxoplasmosis.","volume":"280","author":"Diamant","year":"1980","journal-title":"BMJ"},{"key":"R23-20250614","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1182\/blood-2009-06-225565","article-title":"International consensus report on the investigation and management of primary immune thrombocytopenia.","volume":"115","author":"Provan","year":"2010","journal-title":"Blood"},{"key":"R24-20250614","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/bjh.14515","article-title":"State of the art \u2013 how I manage immune thrombocytopenia.","volume":"177","author":"Cooper","year":"2017","journal-title":"Br J Haematol"},{"key":"R25-20250614","first-page":"129","article-title":"Thrombopenic purpura and acquired toxoplasmosis.","volume":"16","author":"Borderon","year":"1969","journal-title":"Pediatr Ann"},{"key":"R26-20250614","first-page":"439","article-title":"Hematopoiesis during acute toxoplasma gondii infection in mice.","volume":"32","author":"Petakov","year":"2002","journal-title":"Haematologia (Budap)"},{"key":"R27-20250614","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/jth.15125","article-title":"A clinical prediction score for transient versus persistent childhood immune thrombocytopenia.","volume":"19","author":"Schmidt","year":"2021","journal-title":"J Thromb Haemost"},{"key":"R28-20250614","doi-asserted-by":"crossref","first-page":"e0138204","DOI":"10.1371\/journal.pone.0138204","article-title":"A systematic review and meta-analysis of the efficacy of anti-toxoplasma gondii medicines in humans.","volume":"10","author":"Wei","year":"2015","journal-title":"PLoS One"},{"key":"R29-20250614","doi-asserted-by":"crossref","first-page":"e0178379","DOI":"10.1371\/journal.pone.0178379","article-title":"Evidence of selective reporting bias in hematology journals: a systematic review.","volume":"12","author":"Wayant","year":"2017","journal-title":"PLoS One"},{"key":"R30-20250614","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fped.2022.894573","article-title":"Congenital toxoplasmosis: the state of the art.","volume":"10","author":"Bollani","year":"2022","journal-title":"Front Pediatr"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000004067","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,15]],"date-time":"2025-06-15T00:04:10Z","timestamp":1749945850000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000004067"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,11]]},"references-count":30,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000004067","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10,11]]}}}